Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml

Insulin glargine is processed in vivo into soluble 21(A)-Gly-human insulin (M1), the principal moiety responsible for metabolic effects, and subsequently into M2. This sub-study compared metabolism and metabolite pharmacokinetic (PK) profiles of investigational new insulin glargine U300 (Gla-300) wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinstraesser, A, Schmidt, R, Bergmann, K, Dahmen, R, Becker, R H A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237557/
https://www.ncbi.nlm.nih.gov/pubmed/24571126
http://dx.doi.org/10.1111/dom.12283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237557/
https://www.ncbi.nlm.nih.gov/pubmed/24571126
http://dx.doi.org/10.1111/dom.12283

Ejemplares similares